
Opinion|Videos|July 31, 2024
The Heterogeneity of Prostate Cancer
Experts on prostate cancer discuss the heterogeneity of the disease and the rationale for using medications with different mechanisms of action, including androgen deprivation therapy.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
3
Pearls & Perspectives: Expanding Options for Men With Erectile Dysfunction, With Tom Riester
4
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
5














